PTC Appoints Rob Bernshteyn to Board of Directors
BOSTON, Sept. 3, 2024 /PRNewswire/ — PTC (NASDAQ: PTC) today announced that it has appointed Rob Bernshteyn to its Board of Directors, effective September... Read more.
Albatroz Therapeutics Soars into Johnson & Johnson Innovation – JLABS Singapore
SINGAPORE, Sept. 3, 2024 /PRNewswire/ — Albatroz Therapeutics, a biotechnology company developing novel therapies against cancer and other indications, today... Read more.
SANDRIDGE ENERGY, INC. ANNOUNCES CLOSING OF WESTERN ANADARKO BASIN ACQUISITION AND UPDATES FULL-YEAR 2024 GUIDANCE
OKLAHOMA CITY, Sept. 3, 2024 /PRNewswire/ — SandRidge Energy, Inc. (the “Company” or “SandRidge”) (NYSE: SD) today announced the closing... Read more.
SuperCom Secures Additional $2.6 Million in Orders from European Governments with Delivery Expected Within Three Months
TEL AVIV, Israel, Sept. 3, 2024 /PRNewswire/ — SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity... Read more.
ACON Investments Acquires Rymel
WASHINGTON and BOGOTA, Colombia, Sept. 3, 2024 /PRNewswire/ — ACON Investments (“ACON“), a private equity investment firm based in Washington,... Read more.
BlueRock TMS Selected by First Supply to Provide its Transportation Management Software System for New Advanced Distribution Facility in Wisconsin
System to enhance First Supply’s visibility across its entire supply chain while providing best-in-class service for its customers LA CROSSE, Wis., Sept. 3,... Read more.
LAKESIDE HOLDING LAUNCHES NEW PICK & PACK FULFILLMENT SERVICE ACROSS KEY U.S. HUBS FOR LONGSTANDING CHINA LOGISTICS PARTNER
ITASCA, Ill., Sept. 3, 2024 /PRNewswire/ — Lakeside Holding Limited (“Lakeside” or the “Company”) (Nasdaq: LSH), a U.S.-based integrated... Read more.
Evommune Initiates Phase 2 Trial of EVO756, an Oral MRGPRX2 Antagonist, in Chronic Inducible Urticaria
First of two near-term Phase 2 clinical trials to be initiated in Chronic Urticaria Chronic Inducible Urticaria (CIndU) trial will evaluate EVO756 in approximately... Read more.
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
SAN JOSE, Calif., Sept. 3, 2024 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology... Read more.
Morphy’s Brings Fresh-To-Market Trove of Rare and Historical Firearms and Militaria to Auction, Sept. 10-12
Featured: Set of 4 Francolini-engraved Colt SAA Revolvers, 184 lots of NFA arms, WWII German weapons, presentation swords, 1860 ‘Henry’ rifle, gorgeous... Read more.